Curcumin as a MicroRNA Regulator in Cancer: A Review (Q38908322)

7 September 2017

1 reference

title

Curcumin as a MicroRNA Regulator in Cancer: A Review (English)

1 reference

7 September 2017

0 references

1 reference

6

Amirhossein Sahebkar

1 reference

7 September 2017

Amir Abbas Momtazi

1

1 reference

7 September 2017

Fahimeh Shahabipour

2

1 reference

7 September 2017

Sepideh Khatibi

3

1 reference

7 September 2017

Thomas P Johnston

4

1 reference

7 September 2017

Matteo Pirro

5

1 reference

7 September 2017

23 July 2016

1 reference

Reviews of Physiology, Biochemistry and Pharmacology

7 September 2017

1 reference

7 September 2017

171

1 reference

7 September 2017

1-38

1 reference

https://scigraph.springernature.com/pub.10.1007/112_2016_3

7 September 2017

0 references

cites work

Synthesis and biological evaluation of novel curcumin analogs as anti-cancer and anti-angiogenesis agents

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Molecular targets of dietary agents for prevention and therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor-kappaB signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

RETRACTED: Increased Ras GTPase activity is regulated by miRNAs that can be attenuated by CDF treatment in pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Curcumin analogue CDF inhibits pancreatic tumor growth by switching on suppressor microRNAs and attenuating EZH2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Curcumin selectively induces apoptosis in deregulated cyclin D1-expressed cells at G2 phase of cell cycle in a p53-dependent manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Curcumin induces c-jun N-terminal kinase-dependent apoptosis in HCT116 human colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Curcumin intake affects miRNA signature in murine melanoma with mmu-miR-205-5p most significantly altered

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

An investigation of the effects of curcumin on anxiety and depression in obese individuals: A randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Effect of curcumin on the expression of LDL receptor in mouse macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Curcumin and synthetic analogs induce reactive oxygen species and decreases specificity protein (Sp) transcription factors by targeting microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Investigation of the effects of curcumin on serum cytokines in obese individuals: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Pure curcumin decreases the expression of WT1 by upregulation of miR-15a and miR-16-1 in leukemic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Curcumin exerts inhibitory effects on undifferentiated nasopharyngeal carcinoma by inhibiting the expression of miR-125a-5p

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Low levels of natural IgM antibodies against phosphorylcholine are independently associated with vascular remodeling in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Histone acetylation in chromatin structure and transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Synergistic effects of curcumin with emodin against the proliferation and invasion of breast cancer cells through upregulation of miR-34a.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Curcumin inhibits growth of prostate carcinoma via miR-208-mediated CDKN1A activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

21 January 2018

An overview of microRNAs

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Curcumin Reactivates Silenced Tumor Suppressor Gene RARβ by Reducing DNA Methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Difluorinated-curcumin (CDF): a novel curcumin analog is a potent inhibitor of colon cancer stem-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Fungicidal property of Curcuma longa L. rhizome-derived curcumin against phytopathogenic fungi in a greenhouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

miR181b is induced by the chemopreventive polyphenol curcumin and inhibits breast cancer metastasis via down-regulation of the inflammatory cytokines CXCL1 and -2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Curcumin potentiates the anti-arthritic effect of prednisolone in Freund's complete adjuvant-induced arthritic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

MicroRNA genes are transcribed by RNA polymerase II

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Curcumin-induced HDAC inhibition and attenuation of medulloblastoma growth in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Regulation of microRNAs by natural agents: an emerging field in chemoprevention and chemotherapy research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Curcumin modulates miR-19/PTEN/AKT/p53 axis to suppress bisphenol A-induced MCF-7 breast cancer cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

MicroRNA-200a/b influenced the therapeutic effects of curcumin in hepatocellular carcinoma (HCC) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Curcumin inhibits cell growth and invasion through up-regulation of miR-7 in pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Curcumin: A new candidate for melanoma therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Difluorinated Curcumin: A Promising Curcumin Analogue with Improved Anti-Tumor Activity and Pharmacokinetic Profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Role of microRNAs in the Therapeutic Effects of Curcumin in Non-Cancer Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Curcumin regulates miR-21 expression and inhibits invasion and metastasis in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Curcuminoids and sesquiterpenoids in turmeric (Curcuma longa L.) suppress an increase in blood glucose level in type 2 diabetic KK-Ay mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

The drug resistance suppression induced by curcuminoids in colon cancer SW-480 cells is mediated by reactive oxygen species-induced disruption of the microRNA-27a-ZBTB10-Sp axis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Improvement of sulphur mustard-induced chronic pruritus, quality of life and antioxidant status by curcumin: results of a randomised, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

A randomized controlled trial on the anti-inflammatory effects of curcumin in patients with chronic sulphur mustard-induced cutaneous complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Curcuminoid treatment for knee osteoarthritis: a randomized double-blind placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Adjuvant therapy with bioavailability-boosted curcuminoids suppresses systemic inflammation and improves quality of life in patients with solid tumors: a randomized double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Investigation of the efficacy of adjunctive therapy with bioavailability-boosted curcuminoids in major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Curcumin Lowers Serum Lipids and Uric Acid in Subjects With Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Treatment of Non-alcoholic Fatty Liver Disease with Curcumin: A Randomized Placebo-controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Curcumin for malaria therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Mouse pharmacokinetics and metabolism of the curcumin analog, 4-piperidinone,3,5-bis[(2-fluorophenyl)methylene]-acetate(3E,5E) (EF-24; NSC 716993).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Expression of miR-34 is lost in colon cancer which can be re-expressed by a novel agent CDF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Molecular mechanisms for curcumin benefits against ischemic injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Why it is necessary to translate curcumin into clinical practice for the prevention and treatment of metabolic syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Autophagic activation: A key piece of the puzzle for the curcumin-associated cognitive enhancement?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Analgesic Efficacy and Safety of Curcuminoids in Clinical Practice: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Curcuminoids modulate pro-oxidant-antioxidant balance but not the immune response to heat shock protein 27 and oxidized LDL in obese individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Recent advances in pharmacotherapy for hypertriglyceridemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Curcumin downregulates human tumor necrosis factor-α levels: A systematic review and meta-analysis ofrandomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Curcumin modulates microRNA-203-mediated regulation of the Src-Akt axis in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Immunomodulatory effects of nanocurcumin in arsenic-exposed rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Epigenetic drivers and genetic passengers on the road to cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Study of curcumin immunomodulatory effects on reactive astrocyte cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Optimized curcumin formulations for the treatment of Alzheimer's disease: A patent evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Antioxidant activity of curcumin and related compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Curcumin improves synaptic plasticity impairment induced by HIV-1gp120 V3 loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Epigenetic CpG demethylation of the promoter and reactivation of the expression of Neurog1 by curcumin in prostate LNCaP cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Effect of curcumin on miRNA expression in human Y79 retinoblastoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Remodeling chromatin structures for transcription: what happens to the histones?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Curcumin induces cell death in esophageal cancer cells through modulating Notch signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

p53 and its downstream proteins as molecular targets of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Curcumin inhibits in vitro and in vivo chronic myelogenous leukemia cells growth: a possible role for exosomal disposal of miR-21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Identification of differentially expressed proteins in curcumin-treated prostate cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Curcumin as a regulator of epigenetic events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Curcumin mediates chemosensitization to 5-fluorouracil through miRNA-induced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

microRNA-183 is an oncogene targeting Dkk-3 and SMAD4 in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

MicroRNA and cancer--focus on apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Curcumin attenuates brain edema in mice with intracerebral hemorrhage through inhibition of AQP4 and AQP9 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Curcumin induces apoptosis in p53-null Hep3B cells through a TAp73/DNp73-dependent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Flavonoids, cognition, and dementia: actions, mechanisms, and potential therapeutic utility for Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Many roads to maturity: microRNA biogenesis pathways and their regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Curcumin inhibits oral squamous cell carcinoma SCC-9 cells proliferation by regulating miR-9 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Anti-cancer activity of curcumin loaded nanoparticles in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Curcumin reduces the expression of Bcl-2 by upregulating miR-15a and miR-16 in MCF-7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Oral curcumin has anti-arthritic efficacy through somatostatin generation via cAMP/PKA and Ca(2+)/CaMKII signaling pathways in the small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Dendrosomal curcumin increases expression of the long non-coding RNA gene MEG3 via up-regulation of epi-miRs in hepatocellular cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

MiR-21 suppresses the anticancer activities of curcumin by targeting PTEN gene in human non-small cell lung cancer A549 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Curcumin promotes apoptosis in A549/DDP multidrug-resistant human lung adenocarcinoma cells through an miRNA signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

MicroRNA-33b, upregulated by EF24, a curcumin analog, suppresses the epithelial-to-mesenchymal transition (EMT) and migratory potential of melanoma cells by targeting HMGA2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Effect of curcuminoids on oxidative stress: A systematic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F112_2016_3

Retracted: Anti-Tumor Activity of a Novel Compound-CDF Is Mediated by Regulating miR-21, miR-200, and PTEN in Pancreatic Cancer

21 January 2018

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1371/JOURNAL.PONE.0017850

Identifiers

0 references

1 reference